Status:
WITHDRAWN
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
Lead Sponsor:
Plymouth State University
Conditions:
Metabolic Syndrome
Obesity
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
Physical activity is shown to positively reduce the risk of developing both cardiovascular disease and type 2 diabetes. Current guidelines recommend 30-60 minutes of moderate intensity cardiorespirato...
Detailed Description
Sedentary young adults (18-39 years) will be recruited from the community and surrounding areas of Plymouth, NH. In order to be included in the study sample, participants must meet the following crite...
Eligibility Criteria
Inclusion
- Body mass index ≥ 30
- Currently not physically active
- Free of any signs and symptoms of cardiovascular disease, diabetes, chronic kidney disease, and cancer.
Exclusion
- Planning to become pregnant
- Any known signs and symptoms of cardiovascular disease, diabetes, chronic kidney disease, and cancer.
Key Trial Info
Start Date :
September 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03227575
Start Date
September 7 2017
End Date
November 8 2024
Last Update
November 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Draper & Maynard
Plymouth, New Hampshire, United States, 03264
2
Plymouth State University
Plymouth, New Hampshire, United States, 03264